<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM" IndexingMethod="Automated"><PMID Version="2">34239068</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5462</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Gene therapy</Title><ISOAbbreviation>Gene Ther</ISOAbbreviation></Journal><ArticleTitle>Viral vector gene delivery of the novel chaperone protein SRCP1 to modify insoluble protein in in vitro and in vivo models of ALS.</ArticleTitle><Pagination><StartPage>528</StartPage><EndPage>533</EndPage><MedlinePgn>528-533</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41434-021-00276-4</ELocationID><Abstract><AbstractText>Protein misfolding and aggregation are shared features of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), and protein quality control disruption contributes to neuronal toxicity. Therefore, reducing protein aggregation could hold therapeutic potential. We previously identified a novel chaperone protein, serine-rich chaperone protein 1 (SRCP1), that effectively prevents protein aggregation in cell culture and zebrafish models of Huntington's disease. Here we tested whether this benefit extends to aggregated proteins found in ALS. We used viral-mediated expression of SRCP1 in in vitro and in vivo models of ALS. We found that SRCP1 reduced insoluble SOD1 protein levels in HEK293T cells overexpressing either the A4V or G93R mutant SOD1. However, the reduction of insoluble protein was not observed in either mutant C9orf72 or SOD1 ALS iPSC-derived motor neurons infected with a lentivirus expressing SRCP1. SOD1-G93A ALS mice injected with AAV-SRCP1 showed a small but significant reduction in insoluble and soluble SOD1 in both the brain and spinal cord, but SRCP1 expression did not improve mouse survival. These data indicate that SRCP1 likely reduces insoluble protein burden in a protein and/or context-dependent manner indicating a need for additional insight into SRCP1 function and therapeutic potential.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Luecke</LastName><ForeName>Ian W</ForeName><Initials>IW</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lin</LastName><ForeName>Gloria</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santarriaga</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scaglione</LastName><ForeName>K Matthew</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics and Microbiology, Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebert</LastName><ForeName>Allison D</ForeName><Initials>AD</Initials><Identifier Source="ORCID">0000-0001-9676-8548</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA. aebert@mcw.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS112191</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T35 AG029793</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM119544</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Gene Ther</MedlineTA><NlmUniqueID>9421525</NlmUniqueID><ISSNLinking>0969-7128</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D066329">Protein Aggregates</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066329" MajorTopicYN="N">Protein Aggregates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015027" MajorTopicYN="N">Zebrafish</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>48</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34239068</ArticleId><ArticleId IdType="mid">NIHMS1719164</ArticleId><ArticleId IdType="pmc">PMC8741877</ArticleId><ArticleId IdType="doi">10.1038/s41434-021-00276-4</ArticleId><ArticleId IdType="pii">10.1038/s41434-021-00276-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zufiria M, Gil-Bea FJ, Fernandez-Torron R, Poza JJ, Munoz-Blanco JL, Rojas-Garcia R, et al. ALS: a bucket of genes, environment, metabolism and unknown ingredients. Prog Neurobiol. 2016;142:104&#x2013;29. doi: 10.1016/j.pneurobio.2016.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2016.05.004</ArticleId><ArticleId IdType="pubmed">27236050</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno Y, Amari M, Takatama M, Aizawa H, Mihara B, Okamoto K. Immunoreactivities of p62, an ubiqutin-binding protein, in the spinal anterior horn cells of patients with amyotrophic lateral sclerosis. J Neurol Sci. 2006;249:13&#x2013;8. doi: 10.1016/j.jns.2006.05.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2006.05.060</ArticleId><ArticleId IdType="pubmed">16820172</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:223&#x2013;6. doi: 10.1038/nature08971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08971</ArticleId><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HJ, Mitchell JC, Novoselov S, Miller J, Nishimura AL, Scotter EL, et al. The heat shock response plays an important role in TDP-43 clearance: evidence for dysfunction in amyotrophic lateral sclerosis. Brain. 2016;139:1417&#x2013;32. doi: 10.1093/brain/aww028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww028</ArticleId><ArticleId IdType="pmc">PMC4845254</ArticleId><ArticleId IdType="pubmed">26936937</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa V, Sau D, Rusmini P, Boncoraglio A, Onesto E, Bolzoni E, et al. The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS) Hum Mol Genet. 2010;19:3440&#x2013;56. doi: 10.1093/hmg/ddq257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq257</ArticleId><ArticleId IdType="pubmed">20570967</ArticleId></ArticleIdList></Reference><Reference><Citation>Parakh S, Atkin JD. Protein folding alterations in amyotrophic lateral sclerosis. Brain Res. 2016;1648:633&#x2013;49. doi: 10.1016/j.brainres.2016.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.04.010</ArticleId><ArticleId IdType="pubmed">27064076</ArticleId></ArticleIdList></Reference><Reference><Citation>Ries HM, Nussbaum-Krammer C. Shape matters: the complex relationship between aggregation and toxicity in protein-misfolding diseases. Essays Biochem. 2016;60:181&#x2013;90. doi: 10.1042/EBC20160008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/EBC20160008</ArticleId><ArticleId IdType="pubmed">27744334</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith HL, Li W, Cheetham ME. Molecular chaperones and neuronal proteostasis. Semin Cell Dev Biol. 2015;40:142&#x2013;52. doi: 10.1016/j.semcdb.2015.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2015.03.003</ArticleId><ArticleId IdType="pmc">PMC4471145</ArticleId><ArticleId IdType="pubmed">25770416</ArticleId></ArticleIdList></Reference><Reference><Citation>Brehme M, Voisine C, Rolland T, Wachi S, Soper JH, Zhu Y, et al. A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease. Cell Rep. 2014;9:1135&#x2013;50. doi: 10.1016/j.celrep.2014.09.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.09.042</ArticleId><ArticleId IdType="pmc">PMC4255334</ArticleId><ArticleId IdType="pubmed">25437566</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp PS, Akbar MT, Bouri S, Senda A, Joshi K, Chen HJ, et al. Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression. Neurobiol Dis. 2008;30:42&#x2013;55. doi: 10.1016/j.nbd.2007.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.12.002</ArticleId><ArticleId IdType="pubmed">18255302</ArticleId></ArticleIdList></Reference><Reference><Citation>Yerbury JJ, Gower D, Vanags L, Roberts K, Lee JA, Ecroyd H. The small heat shock proteins alphaB-crystallin and Hsp27 suppress SOD1 aggregation in vitro. Cell Stress Chaperones. 2013;18:251&#x2013;7. doi: 10.1007/s12192-012-0371-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-012-0371-1</ArticleId><ArticleId IdType="pmc">PMC3581626</ArticleId><ArticleId IdType="pubmed">22993064</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin PY, Simon SM, Koh WK, Folorunso O, Umbaugh CS, Pierce A. Heat shock factor 1 over-expression protects against exposure of hydrophobic residues on mutant SOD1 and early mortality in a mouse model of amyotrophic lateral sclerosis. Mol Neurodegener. 2013;8:43. doi: 10.1186/1750-1326-8-43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-43</ArticleId><ArticleId IdType="pmc">PMC3907013</ArticleId><ArticleId IdType="pubmed">24256636</ArticleId></ArticleIdList></Reference><Reference><Citation>Seminary ER, Santarriaga S, Wheeler L, Mejaki M, Abrudan J, Demos W, et al. Motor neuron generation from iPSCs from identical twins discordant for amyotrophic lateral sclerosis. Cells. 2020;9:571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7140469</ArticleId><ArticleId IdType="pubmed">32121108</ArticleId></ArticleIdList></Reference><Reference><Citation>Seminary ER, Sison SL, Ebert AD. Modeling protein aggregation and the heat shock response in ALS iPSC-derived motor neurons. Front Neurosci. 2018;12:86. doi: 10.3389/fnins.2018.00086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00086</ArticleId><ArticleId IdType="pmc">PMC5826239</ArticleId><ArticleId IdType="pubmed">29515358</ArticleId></ArticleIdList></Reference><Reference><Citation>Santarriaga S, Petersen A, Ndukwe K, Brandt A, Gerges N, Bruns Scaglione J, et al. The social amoeba Dictyostelium discoideum is highly resistant to polyglutamine aggregation. J Biol Chem. 2015;290:25571&#x2013;8. doi: 10.1074/jbc.M115.676247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.676247</ArticleId><ArticleId IdType="pmc">PMC4646202</ArticleId><ArticleId IdType="pubmed">26330554</ArticleId></ArticleIdList></Reference><Reference><Citation>Santarriaga S, Haver HN, Kanack AJ, Fikejs AS, Sison SL, Egner JM, et al. SRCP1 conveys resistance to polyglutamine aggregation. Mol Cell. 2018;71:216&#x2013;28 e7. doi: 10.1016/j.molcel.2018.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.07.008</ArticleId><ArticleId IdType="pmc">PMC6091221</ArticleId><ArticleId IdType="pubmed">30029002</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson JL, Geser F, Stieber A, Umoh M, Kwong LK, Van Deerlin VM, et al. TDP-43 skeins show properties of amyloid in a subset of ALS cases. Acta Neuropathol. 2013;125:121&#x2013;31. doi: 10.1007/s00401-012-1055-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1055-8</ArticleId><ArticleId IdType="pmc">PMC3536927</ArticleId><ArticleId IdType="pubmed">23124365</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigio EH, Weintraub S, Rademakers R, Baker M, Ahmadian SS, Rademaker A, et al. Frontotemporal lobar degeneration with TDP-43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: clinicopathologic correlation. Neuropathology. 2013;33:122&#x2013;33. doi: 10.1111/j.1440-1789.2012.01332.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2012.01332.x</ArticleId><ArticleId IdType="pmc">PMC3449045</ArticleId><ArticleId IdType="pubmed">22702520</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Chen Y, Zhou X, Kar A, Ray P, Chen X, et al. An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Nat Struct Mol Biol. 2011;18:822&#x2013;30. doi: 10.1038/nsmb.2053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2053</ArticleId><ArticleId IdType="pmc">PMC3357956</ArticleId><ArticleId IdType="pubmed">21666678</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Kwong LK, Sampathu DM, Trojanowski JQ, Lee VM. TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis. Arch Neurol. 2007;64:1388&#x2013;94. doi: 10.1001/archneur.64.10.1388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.64.10.1388</ArticleId><ArticleId IdType="pubmed">17923623</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosoyama T, McGivern JV, Van Dyke JM, Ebert AD, Suzuki M. Derivation of myogenic progenitors directly from human pluripotent stem cells using a sphere-based culture. Stem Cells Transl Med. 2014;3:564&#x2013;74. doi: 10.5966/sctm.2013-0143.</Citation><ArticleIdList><ArticleId IdType="doi">10.5966/sctm.2013-0143</ArticleId><ArticleId IdType="pmc">PMC4006483</ArticleId><ArticleId IdType="pubmed">24657962</ArticleId></ArticleIdList></Reference><Reference><Citation>Sareen D, O&#x2019;Rourke JG, Meera P, Muhammad AKMG, Grant S, Simpkinson M, et al. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9orf72 repeat expansion. Sci Transl Med. 2013;5:208ra149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4090945</ArticleId><ArticleId IdType="pubmed">24154603</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebert AD, Yu J, Rose FF, Jr., Mattis VB, Lorson CL, Thomson JA, et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature. 2009;457:277&#x2013;80. doi: 10.1038/nature07677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07677</ArticleId><ArticleId IdType="pmc">PMC2659408</ArticleId><ArticleId IdType="pubmed">19098894</ArticleId></ArticleIdList></Reference><Reference><Citation>Riedel M, Jou CJ, Lai S, Lux RL, Moreno AP, Spitzer KW, et al. Functional and pharmacological analysis of cardiomyocytes differentiated from human peripheral blood mononuclear-derived pluripotent stem cells. Stem Cell Reports. 2014;3:131&#x2013;41. doi: 10.1016/j.stemcr.2014.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2014.04.017</ArticleId><ArticleId IdType="pmc">PMC4110777</ArticleId><ArticleId IdType="pubmed">25068127</ArticleId></ArticleIdList></Reference><Reference><Citation>McGivern JV, Patitucci TN, Nord JA, Barabas MA, Stucky CL, Ebert AD. Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production. Glia. 2013;61:1418&#x2013;28. doi: 10.1002/glia.22522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22522</ArticleId><ArticleId IdType="pmc">PMC3941074</ArticleId><ArticleId IdType="pubmed">23839956</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury Y, Come J, Piskorowski RA, Salah-Mohellibi N, Chevaleyre V, Peschanski M, et al. Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes. Nat Biotechnol. 2015;33:89&#x2013;96. doi: 10.1038/nbt.3049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3049</ArticleId><ArticleId IdType="pubmed">25383599</ArticleId></ArticleIdList></Reference><Reference><Citation>Brotherton TE, Li Y, Glass JD. Cellular toxicity of mutant SOD1 protein is linked to an easily soluble, non-aggregated form in vitro. Neurobiol Dis. 2013;49:49&#x2013;56. doi: 10.1016/j.nbd.2012.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.08.010</ArticleId><ArticleId IdType="pmc">PMC3549044</ArticleId><ArticleId IdType="pubmed">22926189</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>